Committed to sharing our science

Committed to sharing our science

431 results available

The Discovery of Ulacamten, a Cardiac Myosin Inhibitor for the Treatment of Heart Failure with Preserved Ejection Fraction

ACS Medicinal Chemistry Letters

Ashcraft, L et al.

November 5, 2026
Effect of Aficamten on Cardiac Structure and Function in Nonobstructive Hypertrophic Cardiomyopathy: The ACACIA-HCM CMR Study

Oral Presentation, HCMS 2026

Masri, A et al.

November 6, 2026
Effect of Aficamten on Patient-Reported Health Status in Non-Obstructive Hypertrophic Cardiomyopathy

Oral Presentation, HCMS 2026

Nassif, M et al.

November 6, 2026
Left Ventricular Systolic Dysfunction in Long-Term Aficamten Therapy for Obstructive HCM: A FOREST-HCM Analysis

Poster Presentation, HCMS 2026

Massera, D et al.

November 6, 2026
Left Ventricular Ejection Fraction Reductions During Long-Term Aficamten Treatment in Obstructive Hypertrophic Cardiomyopathy: Findings From FOREST-HCM

Journal of Cardiac Failure

Massera, D et al.

November 6, 2026